Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks making big moves yesterday: Robinhood, Payoneer, Micron, Limbach, and Bristol-Myers Squibb

StockStory - Thu Mar 26, 8:00AM CDT
HOOD

HOOD Cover Image

Check out the companies making headlines yesterday:

Robinhood (NASDAQ:HOOD): Financial services company Robinhood (NASDAQ:HOOD) rose by 4.8% on Wednesday after the company's board of directors approved a new $1.5 billion share repurchase program. See our full article here.

Is now the time to buy Robinhood? Access our full analysis report here, it's free.

Payoneer (NASDAQ:PAYO): Cross-border payment platform Payoneer (NASDAQ:PAYO) rose by 3.4% on Wednesday after BofA Securities initiated coverage on the company with a Buy rating and a $6.00 price target. See our full article here.

Is now the time to buy Payoneer? Access our full analysis report here, it's free.

Micron (NASDAQ:MU): Memory chips maker Micron (NYSE:MU) fell by 4.3% on Wednesday after investors reacted to an announcement from Google that could reduce demand for memory chips See our full article here.

Is now the time to buy Micron? Access our full analysis report here, it's free.

Limbach (NASDAQ:LMB): Building systems company Limbach (NASDAQ:LMB) rose by 3.3% on Wednesday after the stock's positive momentum continued as it detailed its strategic shift toward large, mission-critical customers and its goals for higher profit margins at the ROTH Conference. See our full article here.

Is now the time to buy Limbach? Access our full analysis report here, it's free.

Bristol-Myers Squibb (NYSE:BMY): Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) rose by 2.6% on Wednesday after its positive momentum continued as the company received expanded approvals for its key cancer drug, Opdivo. See our full article here.

Is now the time to buy Bristol-Myers Squibb? Access our full analysis report here, it's free.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.